These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
397 related articles for article (PubMed ID: 15502827)
1. X-linked inheritance of Fanconi anemia complementation group B. Meetei AR; Levitus M; Xue Y; Medhurst AL; Zwaan M; Ling C; Rooimans MA; Bier P; Hoatlin M; Pals G; de Winter JP; Wang W; Joenje H Nat Genet; 2004 Nov; 36(11):1219-24. PubMed ID: 15502827 [TBL] [Abstract][Full Text] [Related]
2. The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia. Levran O; Attwooll C; Henry RT; Milton KL; Neveling K; Rio P; Batish SD; Kalb R; Velleuer E; Barral S; Ott J; Petrini J; Schindler D; Hanenberg H; Auerbach AD Nat Genet; 2005 Sep; 37(9):931-3. PubMed ID: 16116424 [TBL] [Abstract][Full Text] [Related]
3. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1. Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition. Seal S; Barfoot R; Jayatilake H; Smith P; Renwick A; Bascombe L; McGuffog L; Evans DG; Eccles D; Easton DF; Stratton MR; Rahman N; Cancer Res; 2003 Dec; 63(24):8596-9. PubMed ID: 14695169 [TBL] [Abstract][Full Text] [Related]
5. FANCG promotes formation of a newly identified protein complex containing BRCA2, FANCD2 and XRCC3. Wilson JB; Yamamoto K; Marriott AS; Hussain S; Sung P; Hoatlin ME; Mathew CG; Takata M; Thompson LH; Kupfer GM; Jones NJ Oncogene; 2008 Jun; 27(26):3641-52. PubMed ID: 18212739 [TBL] [Abstract][Full Text] [Related]
6. Heterozygosity for p53 (Trp53+/-) accelerates epithelial tumor formation in fanconi anemia complementation group D2 (Fancd2) knockout mice. Houghtaling S; Granville L; Akkari Y; Torimaru Y; Olson S; Finegold M; Grompe M Cancer Res; 2005 Jan; 65(1):85-91. PubMed ID: 15665282 [TBL] [Abstract][Full Text] [Related]
7. FANCE: the link between Fanconi anaemia complex assembly and activity. Pace P; Johnson M; Tan WM; Mosedale G; Sng C; Hoatlin M; de Winter J; Joenje H; Gergely F; Patel KJ EMBO J; 2002 Jul; 21(13):3414-23. PubMed ID: 12093742 [TBL] [Abstract][Full Text] [Related]
8. The interplay of Fanconi anemia proteins in the DNA damage response. Wang X; D'Andrea AD DNA Repair (Amst); 2004; 3(8-9):1063-9. PubMed ID: 15279794 [TBL] [Abstract][Full Text] [Related]
9. The Fanconi anaemia group G gene FANCG is identical with XRCC9. de Winter JP; Waisfisz Q; Rooimans MA; van Berkel CG; Bosnoyan-Collins L; Alon N; Carreau M; Bender O; Demuth I; Schindler D; Pronk JC; Arwert F; Hoehn H; Digweed M; Buchwald M; Joenje H Nat Genet; 1998 Nov; 20(3):281-3. PubMed ID: 9806548 [TBL] [Abstract][Full Text] [Related]
10. Genetic subtyping of Fanconi anemia by comprehensive mutation screening. Ameziane N; Errami A; Léveillé F; Fontaine C; de Vries Y; van Spaendonk RM; de Winter JP; Pals G; Joenje H Hum Mutat; 2008 Jan; 29(1):159-66. PubMed ID: 17924555 [TBL] [Abstract][Full Text] [Related]
11. Biallelic inactivation of BRCA2 in Fanconi anemia. Howlett NG; Taniguchi T; Olson S; Cox B; Waisfisz Q; De Die-Smulders C; Persky N; Grompe M; Joenje H; Pals G; Ikeda H; Fox EA; D'Andrea AD Science; 2002 Jul; 297(5581):606-9. PubMed ID: 12065746 [TBL] [Abstract][Full Text] [Related]
12. C. elegans: a model of Fanconi anemia and ICL repair. Youds JL; Barber LJ; Boulton SJ Mutat Res; 2009 Jul; 668(1-2):103-16. PubMed ID: 19059419 [TBL] [Abstract][Full Text] [Related]
13. The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J. Levitus M; Waisfisz Q; Godthelp BC; de Vries Y; Hussain S; Wiegant WW; Elghalbzouri-Maghrani E; Steltenpool J; Rooimans MA; Pals G; Arwert F; Mathew CG; Zdzienicka MZ; Hiom K; De Winter JP; Joenje H Nat Genet; 2005 Sep; 37(9):934-5. PubMed ID: 16116423 [TBL] [Abstract][Full Text] [Related]
14. Cellular characterization of cells from the Fanconi anemia complementation group, FA-D1/BRCA2. Godthelp BC; van Buul PP; Jaspers NG; Elghalbzouri-Maghrani E; van Duijn-Goedhart A; Arwert F; Joenje H; Zdzienicka MZ Mutat Res; 2006 Oct; 601(1-2):191-201. PubMed ID: 16920162 [TBL] [Abstract][Full Text] [Related]
15. The genetic and molecular basis of Fanconi anemia. de Winter JP; Joenje H Mutat Res; 2009 Jul; 668(1-2):11-9. PubMed ID: 19061902 [TBL] [Abstract][Full Text] [Related]
16. Intermediate DNA repair activity associated with the 322delG allele of the fanconi anemia complementation group C gene. Donahue SL; Lundberg R; Campbell C J Mol Biol; 2004 Oct; 342(5):1443-55. PubMed ID: 15364573 [TBL] [Abstract][Full Text] [Related]
17. Chemosensitizing tumor cells by targeting the Fanconi anemia pathway with an adenovirus overexpressing dominant-negative FANCA. Ferrer M; de Winter JP; Mastenbroek DC; Curiel DT; Gerritsen WR; Giaccone G; Kruyt FA Cancer Gene Ther; 2004 Aug; 11(8):539-46. PubMed ID: 15192709 [TBL] [Abstract][Full Text] [Related]
19. Current knowledge on the pathophysiology of Fanconi anemia: from genes to phenotypes. Yamashita T; Nakahata T Int J Hematol; 2001 Jul; 74(1):33-41. PubMed ID: 11530803 [TBL] [Abstract][Full Text] [Related]
20. [Complex role of the FA proteins in providing genome stability]. Kluzek K; Zdzienicka MZ Postepy Biochem; 2005; 51(4):387-94. PubMed ID: 16676573 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]